RTI Biologics Launches Fortiv™ Porcine Dermis, First Human Implantation Complete

Published: Jun 06, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, is pleased to announce the launch of its Fortiva™ porcine dermis implant at the Abdominal Wall Reconstruction (AWR) Conference in Washington, D.C., June 6-8. This implant positions RTI as the only provider with a comprehensive biologic solutions portfolio for use in hernia repair procedures. Tutopatch™ bovine pericardium, Tutomesh™ fenestrated bovine pericardium and Cortiva™ allograft dermis launched in March. The company’s full line of implants is distributed directly by RTI’s Surgical Specialties business unit.

Help employers find you! Check out all the jobs and post your resume.

Back to news